Beckman Coulter

4300 N. Harbor Blvd.,
Fullerton,
CA 92834
United States of America
Tel: 1 800 742 2345
Fax: 1 800 643 4366

Print Email to a friend

Beckman Coulter, Inc has partnered with pION, Inc. to commercialize the Biomek® FX ADMETox Workstation, providing the best first step in ADMETox screening.

This high-throughput solution employs pION’s PAMPA technology to enable qualification of hits out of screening assays for the desired pharmacological characteristics, permeability of drug candidates across the GI tract and/or the blood/brain barrier.

The PAMPA Evolution 96 software drives the PAMPA assay, collects data and presents data analysis enabling decisions to pursue further development of a drug candidate.

To learn more about Beckman Coulter’s FASTER, BETTER and CHEAPER ADMETox solution, please visit the website above.

Further Information: http://www.beckmancoulteremail.com/admetox



Related Products

New Centerpiece Enhances Performance of Beckman Coulter’s Analytical Ultracentrifuge
Systems provide precise macromolecule aggregation measurement for drug discovery and vaccine development.

New Detection Cartridges Extend Applications of PARADIGM™ Platform
Beckman Coulter releases four new cartridges for the PARADIGM user-configurable and upgradeable multimode reader.

New Centerpiece Enhances Performance of Beckman Coulter’s Analytical Ultracentrifuge
Systems provide precise macromolecule aggregation measurement for drug discovery and vaccine development.

New Detection Cartridges Extend Applications of PARADIGM™ Platform
Beckman Coulter releases four new cartridges for the PARADIGM user-configurable and upgradeable multimode reader.

New Centerpiece Enhances Performance of Beckman Coulter’s Analytical Ultracentrifuge
Systems provide precise macromolecule aggregation measurement for drug discovery and vaccine development.

New Detection Cartridges Extend Applications of PARADIGM™ Platform
Beckman Coulter releases four new cartridges for the PARADIGM user-configurable and upgradeable multimode reader.



Related news from our archive

New Detection Cartridges Expand Applications of Beckman Coulter’s PARADIGM Platform
Beckman Coulter® introduces four detection cartridges for the PARADIGM Detection Platform, its modular plate reader, adding new capabilities for widely used fluorescence and luminescence applications.

Beckman Coulter Announces the Creation of Beckman Coulter Genomics
New Company offers researchers a single genomic services resource with expanded global capabilities.

New Detection Cartridges Expand Applications of Beckman Coulter’s PARADIGM Platform
Beckman Coulter® introduces four detection cartridges for the PARADIGM Detection Platform, its modular plate reader, adding new capabilities for widely used fluorescence and luminescence applications.

Beckman Coulter Announces the Creation of Beckman Coulter Genomics
New Company offers researchers a single genomic services resource with expanded global capabilities.

New Detection Cartridges Expand Applications of Beckman Coulter’s PARADIGM Platform
Beckman Coulter® introduces four detection cartridges for the PARADIGM Detection Platform, its modular plate reader, adding new capabilities for widely used fluorescence and luminescence applications.

Beckman Coulter Announces the Creation of Beckman Coulter Genomics
New Company offers researchers a single genomic services resource with expanded global capabilities.